Javier Lanillos - Concepedia

Author

Javier Lanillos

Centre for Biomedical Network Research on Rare Diseases ORCID

Also Known As

J. Lanillos, Javier Lanillos, Lanillos, Javier

Publications

404

Citations

H-Index

Concepts

All Affiliations

Centre for Biomedical Network Research on Rare Diseases Spanish National Cancer Research Centre Centro de Investigación Biomédica en Red Centro de Investigación Biomédica en Red de Cáncer Hospital Universitario La Paz

About

Javier Lanillos is an author at Centre for Biomedical Network Research on Rare Diseases specializing in medicine, pathology, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	107
2	Pathology	3	3	107
3	Cancer Cell Biology	1	1	39
4	Cancer Genetics	1	1	39
5	Epigenetic Regulation	1	1	39

Javier Lanillos

Publications

375

Citations

H-Index

Page 1

	Year	Citations
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma Bruna Calsina, Elena Piñeiro-Yáñez, Ángel M. Martínez‐Montes, Nature Communications	2023	86
Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma Bruna Calsina, Luis Jaime Castro‐Vega, Rafael Torres‐Pérez, Theranostics	2019	65
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome Juan María Roldán‐Romero, María Santos, Javier Lanillos, Modern Pathology Molecular CharacterizationUrologyPathway AlterationsPoor OutcomeGenitourinary Cancer	2020	48
Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing Cristina Montero‐Conde, Osvaldo Graña‐Castro, Guillermo Martín‐Serrano, International Journal of Cancer GeneticsPathologyCancer BiologySplicing VariantTumor Biology	2019	39
PTEN expression and mutations in <i>TSC1</i>, <i>TSC2</i> and <i>MTOR</i> are associated with response to rapalogs in patients with renal cell carcinoma Juan María Roldán‐Romero, Benoit Beuselinck, María Santos, International Journal of Cancer	2019	29
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data Javier Lanillos, Marta Carcajona, Paolo Maietta, npj Genomic Medicine	2022	24
Sunitinib and Evofosfamide (<scp>TH</scp>-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The <scp>GETNE</scp>-1408 Trial Enrique Grande, Cristina Rodríguez‐Antona, Carlos López, The Oncologist	2021	21
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma María Santos, Javier Lanillos, Juan María Roldán‐Romero, Genetics in Medicine Pathogenic Germline VariantsUrologyGenitourinary CancerMedicinePathology	2021	20
Deubiquitinase <scp>USP9X</scp> loss sensitizes renal cancer cells to <scp>mTOR</scp> inhibition Juan María Roldán‐Romero, Carlos Valdivia, María Santos, International Journal of Cancer	2023	18
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma Sara Mellid, Javier Pardo de Santayana y Coloma, Bruna Calsina, Cancers	2020	14

Page 1